Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza Pairs with Biomax Solutions and AME Bioscience

NEW YORK, June 9 (GenomeWeb News) -- There may not be chirps and tweets coming from the Biomax Optimized Research Environment, a bioinformatics system, or the refurbished used sequencing instruments sold by AME Bioscience, but there will be a Finch there.

The two vendors today announced sales alliances to include Geospiza’s Finch Sequencing Center software within their respective product offerings. Financial details were not disclosed.

Biomax Solutions of Falmouth, Mass., and Geospiza of Seattle will co-develop a bioinformatics package that will be sold under the product name, Optimized Research Environment, for analyzing and managing DNA sequencing data. 

AME Bioscience of Norway will bundle Finch with the used Applied Biosystems and Amersham Bioscience sequencing instruments it sells.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.